RecruitingPhase 4NCT04507412

Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty

Effect of Perioperative Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty for Osteoarthritis, in Terms of Post-operative Pain, Function, Nausea, Hospitalization Length, and Risk of Complications

Sponsor

Christian Candrian

Enrollment

74 participants

Start Date

Sep 9, 2020

Study Type

INTERVENTIONAL

Conditions

Arthroplasty, Replacement, Shoulder

Summary

The aim of the study is to evaluate if intravenous steroid supplementation can provide advantages over routine analgesia protocols in terms of post-operative symptoms (pain and nausea), length of hospital stay, shoulder range of motion, function and patient satisfaction

Eligibility

Min Age: 58 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called dexamethasone for people with arthroplasty, replacement, shoulder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 58 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.